Vikas Khemani-backed Q-Line Biotech IPO subscribed over 2 times on Day 1 as GMP soars to 42%

Vikas Khemani-backed Q-Line Biotech's IPO opened on Wednesday, aiming to raise up to Rs 214.48 crore on NSE Emerge. The company, operating in the in-vitro diagnostics and healthcare solutions segment, saw strong subscription on its first day. Proceeds will be used for working capital, debt repayment, and general corporate purposes.